Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000950328 | SCV001096627 | likely benign | Tuberous sclerosis 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001019915 | SCV001181329 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Division of Genomic Medicine, |
RCV000950328 | SCV001430719 | likely benign | Tuberous sclerosis 2 | 2020-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000950328 | SCV002041290 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043236 | SCV000067037 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |